| Dermatologic Reactions to Immune Checkpoint Inhibitors Skin Toxicities and Immunotherapy |
78 |
| Teledermatology: A Review and Update |
43 |
| Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis |
37 |
| Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails |
28 |
| JAK Inhibitors for Atopic Dermatitis: An Update |
22 |
| Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment |
22 |
| Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis |
20 |
| Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives |
20 |
| Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders |
20 |
| Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update |
17 |
| Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature |
16 |
| Management of Itch in Atopic Dermatitis |
15 |
| Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment |
15 |
| Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis |
14 |
| Vitamin D and the Skin: An Update for Dermatologists |
14 |
| Natural Oils for Skin-Barrier Repair: Ancient Compounds Now Backed by Modern Science |
14 |
| The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis |
14 |
| Probiotic Supplementation for Prevention of Atopic Dermatitis in Infants and Children: A Systematic Review and Meta-analysis |
13 |
| Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment |
12 |
| KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development |
11 |
| Mechanisms of Resistance to Immune Checkpoint Blockade |
11 |
| Granuloma Annulare: A Focused Review of Therapeutic Options |
11 |
| Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis |
11 |
| Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections |
11 |
| Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say? |
11 |
| Drug-Induced Pyoderma Gangrenosum: A Review |
11 |
| Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials |
10 |
| Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study |
10 |
| Acne Scarring Management: Systematic Review and Evaluation of the Evidence |
10 |
| Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review |
10 |
| A Comprehensive Conceptual Model of the Experience of Chronic Itch in Adults |
10 |
| A Review on Pityriasis Rubra Pilaris |
10 |
| Topical Retinoids in Acne Vulgaris: A Systematic Review |
10 |
| Acne, the Skin Microbiome, and Antibiotic Treatment |
9 |
| Monitoring Melanoma Using Circulating Free DNA |
9 |
| Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study |
9 |
| Noninvasive Imaging Tools in the Diagnosis and Treatment of Skin Cancers |
9 |
| Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis |
9 |
| Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis |
9 |
| Daylight Photodynamic Therapy for Actinic Keratoses |
9 |
| Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data |
9 |
| Diagnosis and Treatment of Rosacea Fulminans: A Comprehensive Review |
9 |
| Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases |
8 |
| Diagnosis and Treatment of Vulvar Lichen Sclerosus: An Update for Dermatologists |
8 |
| Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma |
8 |
| Antibody-Based Therapies for Cutaneous T-Cell Lymphoma |
8 |
| Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies |
7 |
| Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups |
7 |
| Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review |
7 |
| Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma |
7 |
